Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.11B |
| 2 |
Snowflake
SNOW
|
+$1.67B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$1.61B |
| 4 |
Shopify
SHOP
|
+$1.42B |
| 5 |
Royalty Pharma
RPRX
|
+$1.15B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PARA
Paramount Global Class B
PARA
|
+$2.27B |
| 2 |
Amazon
AMZN
|
+$2.09B |
| 3 |
Vipshop
VIPS
|
+$1.28B |
| 4 |
Meta Platforms (Facebook)
META
|
+$1.27B |
| 5 |
Alibaba
BABA
|
+$1.04B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.67% |
| 2 | Healthcare | 9.78% |
| 3 | Financials | 9.01% |
| 4 | Communication Services | 8.96% |
| 5 | Consumer Discretionary | 8.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3651
Ducommun
DCO
$3.13B
| $3.74M | ﹤0.01% |
62,266
-5,601
| -8% | -$313K |
|
|
NTP
3652
DELISTED
Nam Tai Property Inc.
NTP
| $3.73M | ﹤0.01% |
302,497
-142,098
| -32% | -$1.33M |
|
|
ECOL
3653
DELISTED
US Ecology, Inc.
ECOL
| $3.73M | ﹤0.01% |
89,488
-23,716
| -21% | -$923K |
|
|
SEVN
3654
Seven Hills Realty Trust
SEVN
$176M
| $3.72M | ﹤0.01% |
310,282
+75,756
| +32% | +$885K |
|
3655
Cartesian Therapeutics
RNAC
$267M
| $3.72M | ﹤0.01% |
27,402
-16,566
| -38% | -$2.06M |
|
|
CET
3656
Central Securities Corp
CET
$1.63B
| $3.71M | ﹤0.01% |
97,998
-7,513
| -7% | -$266K |
|
|
DBD
3657
DELISTED
Diebold Nixdorf Incorporated
DBD
| $3.71M | ﹤0.01% |
262,838
-152,409
| -37% | -$2.1M |
|
3658
TIM SA
TIMB
$8.29B
| $3.71M | ﹤0.01% |
327,052
-1,519,114
| -82% | -$18.6M |
|
|
ICPT
3659
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $3.71M | ﹤0.01% |
160,721
-143,776
| -47% | -$4.01M |
|
|
LCI
3660
DELISTED
Lannett Company, Inc.
LCI
| $3.71M | ﹤0.01% |
175,546
+43,583
| +33% | +$1.15M |
|
3661
CEMIG Ordinary Shares
CIG.C
$8.38B
| $3.71M | ﹤0.01% |
2,197,105
-350,455
| -14% | -$597K |
|
3662
OFS Capital
OFS
$48.1M
| $3.69M | ﹤0.01% |
419,965
+49,742
| +13% | +$388K |
|
3663
Valvoline
VVV
$4.36B
| $3.68M | ﹤0.01% |
141,293
-243,866
| -63% | -$6.08M |
|
3664
Evolent Health
EVH
$529M
| $3.67M | ﹤0.01% |
181,563
-114,804
| -39% | -$2.18M |
|
3665
iShares iBonds Dec 2027 Term Muni Bond ETF
IBMP
$659M
| $3.66M | ﹤0.01% |
136,016
+47,535
| +54% | +$1.29M |
|
|
INN
3666
Summit Hotel Properties
INN
$651M
| $3.66M | ﹤0.01% |
360,291
-76,587
| -18% | -$740K |
|
3667
Lantheus
LNTH
$6.59B
| $3.66M | ﹤0.01% |
171,210
-41,476
| -20% | -$752K |
|
|
MVT
3668
DELISTED
BlackRock MuniVest Fund II
MVT
| $3.66M | ﹤0.01% |
244,574
+51,905
| +27% | +$781K |
|
|
RCS
3669
PIMCO Strategic Income Fund
RCS
$250M
| $3.66M | ﹤0.01% |
498,989
-79,025
| -14% | -$563K |
|
3670
Arcturus Therapeutics
ARCT
$234M
| $3.66M | ﹤0.01% |
88,525
+47,900
| +118% | +$2.86M |
|
3671
iShares MSCI Intl Momentum Factor ETF
IMTM
$4.33B
| $3.65M | ﹤0.01% |
97,145
+12,154
| +14% | +$464K |
|
3672
Herc Holdings
HRI
$5.8B
| $3.65M | ﹤0.01% |
35,999
-51,271
| -59% | -$4.15M |
|
|
EHI
3673
Western Asset Global High Income Fund
EHI
$177M
| $3.65M | ﹤0.01% |
347,159
-3,762
| -1% | -$38.5K |
|
3674
IES Holdings
IESC
$15.1B
| $3.64M | ﹤0.01% |
72,192
+8,623
| +14% | +$415K |
|
3675
Cohen & Steers
CNS
$4.36B
| $3.64M | ﹤0.01% |
55,655
-1,365
| -2% | -$93.3K |
|
Similar funds
Morgan Stanley's Q1 2021 Portfolio in Review
As of Q1 2021, Morgan Stanley held 7,749 positions worth $681B, up 5.1% from $647B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Morgan Stanley's Q1 2021 filing shows 618 new, 3,173 increased, 3,213 reduced and 188 closed positions. Its largest new stake was Coupang: 16,573,913 shares worth $818M. The largest sale was Paramount Global Class B, an estimated $2.27B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Healthcare and Financials.
- Morgan Stanley's largest Q1 2021 buy was Coupang: 16,573,913 shares worth $818M.
- Morgan Stanley added most to State Street SPDR S&P 500 ETF Trust in Q1 2021, an estimated $3.11B increase.
- Morgan Stanley's biggest Q1 2021 reduction was Paramount Global Class B, cutting an estimated $2.27B.
- Morgan Stanley fully exited Tiffany & Co. in Q1 2021, selling an estimated $318M.
- Morgan Stanley's ten largest holdings make up 16% of its $681B portfolio in Q1 2021.
- Morgan Stanley opened 618 new positions and closed 188 in Q1 2021.
- Morgan Stanley's portfolio value rose 5.1% quarter-over-quarter to $681B.
Based on Morgan Stanley's 13F filing for Q1 2021, filed 17 May 2021.